$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
AZD9291多久耐药?
2025-10-19 11:44:20
Check Details
AZD9291治疗肺癌效果如何呢?
2025-10-19 11:44:20
Check Details
Tagrix是治疗什么的?
2025-10-19 11:44:20
Check Details
Tagrix的使用说明
2025-10-19 11:44:20
Check Details
Osicent疗效好吗?
2025-10-19 11:44:20
Check Details
劳拉替尼一个月多少钱?
2025-10-19 11:44:20
Check Details
劳拉替尼
2025-10-19 11:44:20
Check Details
劳拉替尼中国上市了吗?
2025-10-19 11:44:20
Check Details
劳拉替尼列入医保了吗?
2025-10-19 11:44:20
Check Details
劳拉替尼使用说明
2025-10-19 11:44:20
Check Details
劳拉替尼的获批适应症
2025-10-19 11:44:20
Check Details
劳拉替尼效果好吗?
2025-10-19 11:44:20
Check Details
1
2
...
9339
9340
9341
9342
9343
9344
9345
...
10211
10212
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
2
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
3
Opicapone Contraindications: Essential Restrictions for At-Risk Groups
4
Finerenone: An Innovative Treatment for Diabetic Kidney Disease
5
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
6
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
7
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
8
Sirolimus (Rapamune) Comprehensive Clinical Guide
9
Lusutrombopag Efficacy, Dosage and Storage Instructions
10
Icotyde (Icotrokinra) Side Effects, Pharmacokinetics and Storage Instructions
11
Cemiplimab (Libtayo) Drug Information
12
Enfortumab Vedotin (Padcev): Nectin-4-Targeted ADC for Advanced Urothelial Carcinoma